David Russell Gaugh
CIK: 0002075974
Associated companies
Transaction History
| AMPH | ▲ Buy | Grant | 8,143 | $0 | 6/1/2026 | View on chart |
| AMPH | ▲ Buy | Grant | 6,304 | $0 | 7/18/2025 | View on chart |
| AMPH | ▲ Buy | Grant | 8,143 | $0 | 6/1/2026 | View on chart |
| AMPH | ▲ Buy | Grant | 6,304 | $0 | 7/18/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Amphastar (AMPH) Cited as Safe-and-Steady Stock in Yahoo Analysis
A recent Yahoo Finance article highlighted Amphastar Pharmaceuticals as a 'safe-and-steady' stock worth researching further. This positive framing contrasts with other companies facing challenges, suggesting the market views AMPH as a relatively stable option. The stock currently trades with a trailing P/E of 14.2, which is lower than the average analyst target price of $22.50.
Amphastar (AMPH) Cited as Safe-and-Steady Stock in Yahoo Analysis. A recent Yahoo Finance article highlighted Amphastar Pharmaceuticals as a 'safe-and-steady' stock worth researching further. This positive framing contrasts with other companies facing challenges, suggesting the market views AMPH as a relatively stable option. The stock currently trades with a trailing P/E of 14.2, which is lower than the average analyst target price of $22.50.